NANOFORM CARDIOVASCULAR THERAPEUTICS LTD has a total of 12 patent applications. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Hungary. Its main competitors in its focus markets pharmaceuticals, machines and organic fine chemistry are VOKKHARDT LTD, LYOTROPIC THERAPEUTICS INC and MELINTA SUBSIDIARY CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Hungary | 2 | |
#4 | Australia | 1 | |
#5 | China | 1 | |
#6 | Israel | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Organic fine chemistry | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Heterocyclic compounds | |
#5 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Darvas Ferenc | 10 |
#2 | Filipcsei Genoveva | 9 |
#3 | Oetvoes Zsolt | 8 |
#4 | Heltovics Gabor | 7 |
#5 | Pongracz Katalin | 3 |
#6 | Oetvoes Zsolt Dr | 1 |
#7 | Filipcsei Genoveva Dr | 1 |
#8 | Ötvös Zsolt | 1 |
#9 | Heltovics Gábor | 1 |
#10 | Otvos Zsolt | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011158052A1 | Nanostructured ezetimibe compositions, process for the preparation thereof and pharmaceutical compositions containing them | |
HUE037747T2 | Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them | |
EP2442795A2 | Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them | |
HU1000299D0 | Nanostructured atorvastatin, its pharmaceutically acceptable salts and pharmaceutical compositions containing them and process for their preparation |